BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 31929533)

  • 1. Epidemiological characteristics of cryptococcal meningoencephalitis associated with Cryptococcus neoformans var. grubii from HIV-infected patients in Madagascar: A cross-sectional study.
    Rakotoarivelo RA; Raberahona M; Rasamoelina T; Rabezanahary A; Rakotomalala FA; Razafinambinintsoa T; Bénet T; Vanhems P; Randria MJD; Romanò L; Cogliati M; Cornet M; Rakoto Andrianarivelo M
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007984. PubMed ID: 31929533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
    BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
    Bertout S; Drakulovski P; Kouanfack C; Krasteva D; Ngouana T; Dunyach-Rémy C; Dongtsa J; Aghokeng A; Delaporte E; Koulla-Shiro S; Reynes J; Mallié M
    Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.
    Chau TT; Mai NH; Phu NH; Nghia HD; Chuong LV; Sinh DX; Duong VA; Diep PT; Campbell JI; Baker S; Hien TT; Lalloo DG; Farrar JJ; Day JN
    BMC Infect Dis; 2010 Jul; 10():199. PubMed ID: 20618932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe.
    Nyazika TK; Hagen F; Machiridza T; Kutepa M; Masanganise F; Hendrickx M; Boekhout T; Magombei-Majinjiwa T; Siziba N; Chin'ombe N; Mateveke K; Meis JF; Robertson VJ
    J Med Microbiol; 2016 Nov; 65(11):1281-1288. PubMed ID: 27638836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
    Nascimento E; Vitali LH; Kress MRVZ; Martinez R
    Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the relationship between drug susceptibility of Cryptococcus neoformans isolates and mortality in HIV-negative cryptococcal meningitis.
    Su Z; Wei H; Liu J; Li C; Xu Z; Yuan D; Dai K; Peng F; Jiang Y
    J Glob Antimicrob Resist; 2024 Mar; 36():167-174. PubMed ID: 38141953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.
    Day JN; Hoang TN; Duong AV; Hong CT; Diep PT; Campbell JI; Sieu TP; Hien TT; Bui T; Boni MF; Lalloo DG; Carter D; Baker S; Farrar JJ
    J Clin Microbiol; 2011 Feb; 49(2):658-64. PubMed ID: 21159929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
    Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomics of Cryptococcus neoformans var. grubii associated with meningitis in HIV infected and uninfected patients in Vietnam.
    Day JN; Qihui S; Thanh LT; Trieu PH; Van AD; Thu NH; Chau TTH; Lan NPH; Chau NVV; Ashton PM; Thwaites GE; Boni MF; Wolbers M; Nagarajan N; Tan PBO; Baker S
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005628. PubMed ID: 28614360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
    Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
    Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe.
    Nyazika TK; Herkert PF; Hagen F; Mateveke K; Robertson VJ; Meis JF
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):289-292. PubMed ID: 27608538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient.
    Kammalac Ngouana T; Drakulovski P; Krasteva D; Kouanfack C; Reynes J; Delaporte E; Boyom FF; Mallié M; Bertout S
    J Med Microbiol; 2016 Jul; 65(7):579-589. PubMed ID: 27100672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of two cases of cryptococcosis in Tripoli, Libya, infected with Cryptococcus neoformans isolates present in the urban area.
    Ellabib MS; Krema ZA; Allafi AA; Cogliati M
    J Mycol Med; 2017 Sep; 27(3):421-424. PubMed ID: 28576330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil.
    Ferreira MF; Brito-Santos F; Trilles L; Almeida MA; Wanke B; Veloso VG; Nunes EP; Lazera MDS
    Mycoses; 2020 Feb; 63(2):145-150. PubMed ID: 31715053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii.
    Van TT; Kim TH; Butler-Wu SM
    Clin Microbiol Infect; 2020 Oct; 26(10):1375-1379. PubMed ID: 31972318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
    Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
    J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.